SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

BG Medicine, Inc. (BGMD)

Add BGMD Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board:
Last Post: 9/28/2016 5:25:25 AM - Followers: 47 - Board type: Free - Posts Today: 0

Welcome to BG Medicine Inc. (BGMD) Board!!

BG Medicine, Inc. is dedicated to developing and delivering innovative solutions for healthcare providers that

provide insight and transform the clinical care of heart failure and related disorders.

galectin-3 mechanism of action video



Paul R. Sohmer, M.D. / President and CEOPaul R. Sohmer, M.D. joined BG Medicine in May of 2013 as President, CEO and member of the board of directors. Dr. Sohmer served as President and Chief Executive Officer of Viracor-IBT Laboratories, Inc., a diagnostic and research laboratory specializing in allergy, immunology, and infectious disease testing from January 2011 to September of 2012. Prior to joining Viracor-IBT Laboratories, from February 2009 to January 2011, Dr. Sohmer served as Chief Executive Officer of Orthocon, Inc., a company that develops, manufactures, markets, and sells implantable products designed to stop bone bleeding. From 2007 to 2009, Dr. Sohmer served on the RadPharm, Inc. board of directors, and from 2008 to 2009, he served as chairman of the board of directors of Molecular Biometrics, Inc. Dr. Sohmer served as Interim CEO of Cylex, Inc. from January through March of 2008 and CEO of Pathway Diagnostics from May to September of 2008. From June 2000 to December 2006, Dr. Sohmer served as Chairman, President and Chief Executive Officer of TriPath Imaging, Inc. (NASDAQ:TPTH). From 1997 to 2000, Dr. Sohmer served as President and Chief Executive Officer of Neuromedical Systems, Inc. (NASDAQ:NSIX). From 1992 to 1996, Dr. Sohmer served as President and Chief Executive Officer of Genetrix, Inc., a genetic testing lab. From 1991-1992, Dr. Sohmer served as Vice President of Professional Services for Nichols Institute. From 1985 to 1991, Dr. Sohmer served as President and Chief Executive Officer of Pathology Institute, Inc., where he led the first commercial introduction of polymerase chain reaction (PCR) for diagnosis of HIV and founded the Chiron Reference Laboratory. Dr. Sohmer received his B.A. from Northwestern University and M.D. from the Chicago Medical School. Dr. Sohmer was named the Ernst and Young Carolinas Life Sciences Entrepreneur of the Year in 2005.

Stephen Hall / Executive Vice President, Chief Financial Office
Mr. Hall joined BG Medicine from Stemline Therapeutics, Inc., a publicly traded clinical stage biopharmaceutical company, where he held the position of Vice President Finance, Treasurer, Principal Financial and Chief Accounting Officer and assisted in financings in excess of $100m. Prior to Stemline, Mr. Hall served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech, Inc. Mr. Hall, a certified public accountant, began his professional career with Peat, Marwick, Mitchell & Co., in Chicago, IL. In addition to his experience as an operating CFO, he spent nearly 10 years in commercial banking. He received his AB degree from Harvard College and MBA from Stanford University Graduate School of Business.

Aram Adourian, Ph.D. / Senior Vice President and Chief Scientific Officer
Dr. Adourian joined BG Medicine from the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. While at MIT, he served as Project Manager for Bioinformatics specializing in the development of novel systems and approaches for biomolecular sequencing, analysis and modeling. Dr. Adourian earned his Ph.D. at Harvard University in Statistical Physics, where he was a recipient of the Rudenberg Research Prize, and received his undergraduate degree in Physics from Cornell University.

Raul Diaz / Vice President, Operations and Information Technologies
Mr. Diaz joined BG Medicine from Newcogen Group Inc.  While at Newcogen Group, he served as Director of Information Technologies where he was responsible for all aspects of the organization’s information technology infrastructure.  Prior to Newcogen, Mr. Diaz spent years as a consultant specializing in information technology architecture, compliance, knowledge management and business continuity.  Mr. Diaz received a Bachelor’s degree in Electrical Engineering from the University of Massachusetts Lowell.


BG Medicine, Inc.                       
880 Winter Street
Suite 210
Waltham, MA 02451
+ 1 (781) 890.1199


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 02:14:20 PM
BGMD News: Proxy Statement (definitive) (def 14a) 06/23/2016 08:16:36 AM
BGMD News: Termination of Registration of a Class of Security Under Section 12(b) (15-12b) 05/05/2016 04:20:30 PM
BGMD News: Statement of Changes in Beneficial Ownership (4) 05/04/2016 06:16:48 PM
BGMD News: Confidential Treatment Order (ct Order) 05/04/2016 11:14:43 AM
#1777  Sticky Note $BGMD recent news/filings mick 01/18/16 03:27:33 PM
#1840   Bg Medicine, Inc. (P (BGMD) mick 09/28/16 05:25:25 AM
#1839   I ask for idea/ share insight....bartchart? learning curve 09/22/16 11:17:36 PM
#1838   Come on some news would be great looks kcbigbucks 09/22/16 01:42:04 PM
#1837   I thought the DIP loan was the basis....for learning curve 09/21/16 01:31:18 AM
#1836   If memory serves, the debt was taken care ToldYaSo 09/20/16 09:32:10 AM
#1835   I'm working on this a estimation was learning curve 09/19/16 10:42:41 PM
#1834   BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 mick 09/18/16 11:48:06 AM
#1833   Bg Medicine, Inc. (P (BGMD) mick 09/18/16 11:47:54 AM
#1832   Can anyone share info, is money done October? Tate 09/17/16 08:06:23 AM
#1831   Initial Statement of Beneficial Ownership (3) "Edgar (US mick 09/15/16 11:05:54 PM
#1830 mick 09/15/16 11:04:49 PM
#1829   need some updates Bg Medicine, Inc. (P (BGMD) mick 09/15/16 11:04:08 PM
#1828   What's your thought here mick? learning curve 09/15/16 11:02:21 PM
#1827   BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 mick 09/03/16 03:53:11 PM
#1826   Bg Medicine, Inc. (P (BGMD) mick 09/03/16 03:52:54 PM
#1825   BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 mick 08/13/16 05:15:44 PM
#1824   Bg Medicine, Inc. (P (BGMD) mick 08/13/16 05:15:32 PM
#1823   What time is stockholder meeting and is anyone going? kcbigbucks 08/05/16 11:45:48 AM
#1822   BGMD News: Initial Statement of Beneficial Ownership (3) 06/27/2016 mick 07/23/16 10:46:33 PM
#1821   Bg Medicine, Inc. (P (BGMD) mick 07/23/16 10:46:26 PM
#1820   Nice bid sitting there. dheminger 07/14/16 02:37:10 PM
#1819   BGMD News: Termination of Registration of a Class mick 06/21/16 04:30:43 PM
#1818   Bg Medicine, Inc. (P (BGMD) mick 06/21/16 04:30:36 PM
#1817   We are not sure.. The product still moving forward.. dheminger 06/15/16 03:59:14 PM
#1816   WHY TERMINATE REGISTRATION ????? BGMD mick 06/15/16 12:09:49 PM
#1815 mick 06/15/16 12:07:59 PM
#1814   BGMD News: Termination of Registration of a Class mick 05/30/16 01:14:28 PM
#1813   Bg Medicine, Inc. (P (BGMD) mick 05/30/16 01:14:08 PM
#1812   New Report 5/26/16, out of London featuring BG BlueRayn 05/28/16 12:24:18 PM
#1811   BGMD News: Termination of Registration of a Class mick 05/20/16 02:18:42 PM
#1810   Bg Medicine, Inc. (P (BGMD) mick 05/20/16 02:18:25 PM
#1809   We can only hope kcbigbucks 05/03/16 11:36:16 AM
#1808   $BGMD interesting trading going on here. Someone in dheminger 05/03/16 11:25:51 AM
#1807   BGMD News: Amended Annual Report (10-k/a) 04/29/2016 04:30:23 PM mick 04/30/16 10:59:55 AM
#1806   Bg Medicine, Inc. (Q (BGMD) mick 04/30/16 10:59:50 AM
#1805   I have not been here for awhile... diannedawn 04/27/16 11:39:15 PM
#1804   Bg Medicine, Inc. (Q (BGMD) mick 04/13/16 01:55:50 PM
#1803   I don't know what anyone else thinks but dheminger 04/01/16 03:28:07 PM
#1802   Some of that was me buying but only kcbigbucks 04/01/16 12:11:12 PM
#1801   Well, someone bought 500k shares already. Can't b BlueRayn 04/01/16 11:51:10 AM
#1800   Seems this company has big problem! hondaboost 04/01/16 11:16:31 AM
#1799   Could be good.....or bad.... ToldYaSo 03/31/16 10:33:26 PM
#1798   Sure would be nice. Hah dheminger 03/31/16 10:21:57 PM
#1797   April fools, right? Haha Tate 03/31/16 09:42:42 PM
#1796   I'm with you - or I guess I'm kcbigbucks 03/31/16 07:22:14 PM
#1795   I'll have to research previous companies went dark Tate 03/31/16 07:19:37 PM
#1794   They are going Dark lots of speculation here.. dheminger 03/31/16 07:13:56 PM
#1793   What was the filings for 2 days ago? Tate 03/31/16 06:57:14 PM
#1792   Lawsuit? Tate 03/31/16 06:55:02 PM
#1791   10-K was due yesterday, so I'm guessing we'll georgesk 03/31/16 11:00:04 AM